Top Pharmaceuticals companies in Switzerland by Receivables
Switzerland
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 15.42 B
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
| 2 |
USD 9.38 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 3 |
USD 2.82 B
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 4 |
USD 2.63 B
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 5 |
USD 2.20 B
|
Dec. 31, 2023 | USD 73.83 | -0.24% |
|
Switzerland |
|
| 6 |
USD 2.11 B
|
Dec. 31, 2023 | USD 82.92 | 0.05% |
|
Switzerland |
|
| 7 |
USD 1.70 B
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 8 |
USD 577.23 M
|
Dec. 31, 2023 | USD 84.29 | 1.29% |
|
Switzerland |
|
| 9 |
USD 565.43 M
|
Dec. 31, 2023 | USD 129.81 | 2.09% |
|
Switzerland |
|
| 10 |
USD 485.47 M
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 11 |
USD 269.85 M
|
Dec. 31, 2023 | USD 140.65 | 0.97% |
|
Switzerland |
|
| 12 |
USD 230.62 M
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 13 |
USD 209.16 M
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 14 |
USD 200.00 M
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 15 |
USD 141.92 M
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 16 |
USD 104.47 M
|
Dec. 31, 2023 | USD 119.40 | 0.87% |
|
Switzerland |
|
| 17 |
USD 88.73 M
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 18 |
USD 84.45 M
|
Dec. 31, 2023 | USD 85.22 | -0.53% |
|
Switzerland |
|
| 19 |
USD 69.01 M
|
Dec. 31, 2023 | USD 11.09 | -3.14% |
|
Switzerland |
|
| 20 |
USD 65.79 M
|
Dec. 31, 2023 | USD 19.40 | 2.88% |
|
Switzerland |
|
| 21 |
USD 49.67 M
|
Dec. 31, 2023 | USD 165.41 | 0.50% |
|
Switzerland |
|
| 22 |
USD 48.07 M
|
Dec. 31, 2023 | USD 73.39 | 4.71% |
|
Switzerland |
|
| 23 |
USD 42.03 M
|
Dec. 31, 2023 | USD 56.52 | -0.28% |
|
Switzerland |
|
| 24 |
USD 33.13 M
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 25 |
USD 31.44 M
|
Dec. 31, 2023 | USD 81.72 | -0.97% |
|
Switzerland |
|
| 26 |
USD 25.18 M
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 27 |
USD 17.87 M
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 28 |
USD 9.05 M
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 29 |
USD 2.07 M
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 30 |
USD 1.43 M
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
|
| 31 |
USD 1.06 M
|
Dec. 31, 2023 | USD 46.50 | 2.74% |
|
Switzerland |
|
| 32 |
USD 522.61 K
|
Dec. 31, 2023 | USD 14.50 | 8.00% |
|
Switzerland |
|
| 33 |
USD 179.67 K
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 34 |
USD 0.00
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 35 |
USD 0.00
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Switzerland has the highest Receivables ?
The Pharmaceuticals company in Switzerland with the highest Receivables is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 15.42 B.
-
Which Pharmaceuticals company in Switzerland has the lowest Receivables ?
The Pharmaceuticals company in Switzerland with the lowest Receivables is PolyPeptide Group AG (Swiss Stock Exchange: PPGN.SW) at USD 0.00.
-
What are the top 10 Pharmaceuticals companies in Switzerland by Receivables ?
The top 10 Pharmaceuticals companies in Switzerland by Receivables are Roche Holding AG, Novartis AG, DSM-Firmenich AG, Sandoz Group AG, DKSH Holding AG, Alcon Inc., Lonza Group AG, Galenica AG, Straumann Holding AG and Siegfried Holding AG.
-
What are the bottom 10 Pharmaceuticals companies in Switzerland by Receivables ?
The bottom 10 Pharmaceuticals companies in Switzerland by Receivables are PolyPeptide Group AG, Dottikon Es Holding AG, Addex Therapeutics Ltd, Santhera Pharmaceuticals Holding AG, MoonLake Immunotherapeutics, Oculis Holding AG, Molecular Partners AG, Kuros Biosciences AG, AC Immune SA and ADC Therapeutics SA.